Result of AGM
Oxford BioDynamics Plc announced that all resolutions proposed at its Annual General Meeting were passed, with the financial statements and director reports receiving 99.96% approval. However, resolutions concerning the Remuneration Committee report and the re-election of Dr. David Holbrook saw significant opposition, with 37.26% and 37.30% of votes cast against them respectively. The Board acknowledged this shareholder feedback and plans to consult further to understand these concerns. Special resolutions regarding the disapplication of pre-emption rights and market purchases of shares were approved with over 96% of votes in favour.
Select text to share a quote on X · sign in to keep highlights & notes in your OBD notes
Oxford, UK - 26 January 2026 - Oxford BioDynamics Plc (AIM: OBD, the Company), a precision clinical diagnostics company bringing specific and sensitive tests to the practice of medicine based on its EpiSwitch® 3D genomics platform, announces that all resolutions proposed at the Company's Annual General Meeting, held earlier today, were duly passed. The proxy votes received for the AGM were as shown below:
| Resolution | Votes for | % | Votes against | % | Chairman's Discretion | % | Abstentions / Votes withheld |
|---|---|---|---|---|---|---|---|
| Ordinary Resolutions | |||||||
| 1. To receive the financial statements and the reports of the Directors and the Auditors for the year ended 30 September 2025 | 1,913,765,673 | 99.96 | 13,252 | 0.00 | 722,754 | 0.04 | 687,222 |
| 2. To approve the report of the Remuneration Committee for the year ended 30 September 2025 | 1,200,415,738 | 62.71 | 713,218,083 | 37.26 | 722,754 | 0.04 | 832,326 |
| 3. To elect Peter Presland as a Director of the Company | 1,910,939,324 | 99.82 | 2,808,322 | 0.15 | 722,754 | 0.04 | 718,501 |
| 4. To re-elect Dr Alexandre Akoulitchev as a Director of the Company | 1,910,863,980 | 99.81 | 2,881,251 | 0.15 | 722,754 | 0.04 | 720,916 |
| 5. To re-elect Dr David Holbrook as a Director of the Company | 1,199,722,309 | 62.67 | 714,042,922 | 37.30 | 722,754 | 0.04 | 700,916 |
| 6. To re-elect Iain Ross as a Director of the Company | 1,907,689,355 | 99.64 | 6,075,280 | 0.32 | 722,754 | 0.04 | 701,512 |
| 7. To re-elect Paul Stockdale as a Director of the Company | 1,910,898,407 | 99.81 | 2,866,824 | 0.15 | 722,754 | 0.04 | 700,916 |
| 8. To re-appoint Grant Thornton UK LLP as Auditors of the Company | 1,913,079,280 | 99.93 | 676,192 | 0.04 | 722,754 | 0.04 | 710,675 |
| 9. To authorise the Directors to set the remuneration of the Auditor | 1,911,916,081 | 99.87 | 1,827,754 | 0.10 | 722,754 | 0.04 | 722,312 |
| 10. To authorise the Directors to allot shares in the Company | 1,910,460,099 | 99.80 | 3,113,162 | 0.16 | 722,754 | 0.04 | 892,886 |
| Special Resolutions | |||||||
| 11. To disapply statutory pre-emption rights in connection with a rights issue or other pre-emptive issue | 1,845,833,984 | 96.42 | 67,888,556 | 3.55 | 722,754 | 0.04 | 743,607 |
| 12. To disapply statutory pre-emption rights in connection with an acquisition or a specified capital investment | 1,846,582,870 | 96.46 | 67,136,765 | 3.51 | 722,754 | 0.04 | 746,512 |
| 13. To authorise the Company to make market purchases of its own shares | 1,852,677,167 | 96.77 | 61,083,956 | 3.19 | 722,754 | 0.04 | 705,024 |
The Board notes the proportion of shareholders' votes which were against ordinary resolutions two and five. The Board intends to consult with shareholders to understand their views.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.